GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » VentriPoint Diagnostics Ltd (FRA:5V7) » Definitions » Market Cap

VentriPoint Diagnostics (FRA:5V7) Market Cap : €11.60 Mil (As of Dec. 11, 2024)


View and export this data going back to 2017. Start your Free Trial

What is VentriPoint Diagnostics Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). VentriPoint Diagnostics's share price for the quarter that ended in Sep. 2024 was €0.099. VentriPoint Diagnostics's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 157.68 Mil. Therefore, VentriPoint Diagnostics's market cap for the quarter that ended in Sep. 2024 was €15.61 Mil.

VentriPoint Diagnostics's quarterly market cap declined from Mar. 2024 (€22.01 Mil) to Jun. 2024 (€20.59 Mil) and declined from Jun. 2024 (€20.59 Mil) to Sep. 2024 (€15.61 Mil).

VentriPoint Diagnostics's annual market cap declined from Dec. 2021 (€34.53 Mil) to Dec. 2022 (€28.23 Mil) but then increased from Dec. 2022 (€28.23 Mil) to Dec. 2023 (€31.68 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. VentriPoint Diagnostics's Enterprise Value for Today is €12.49 Mil.


VentriPoint Diagnostics Market Cap Historical Data

The historical data trend for VentriPoint Diagnostics's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VentriPoint Diagnostics Market Cap Chart

VentriPoint Diagnostics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.78 2.39 34.53 28.23 31.68

VentriPoint Diagnostics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.92 31.68 22.01 20.59 15.61

Competitive Comparison of VentriPoint Diagnostics's Market Cap

For the Medical Devices subindustry, VentriPoint Diagnostics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


VentriPoint Diagnostics's Market Cap Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, VentriPoint Diagnostics's Market Cap distribution charts can be found below:

* The bar in red indicates where VentriPoint Diagnostics's Market Cap falls into.



VentriPoint Diagnostics Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

VentriPoint Diagnostics's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=€0.202*156.824
=€31.68

VentriPoint Diagnostics's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )=Share Price (Q: Sep. 2024 )*Shares Outstanding (EOP) (Q: Sep. 2024 )
=€0.099*157.677
=€15.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


VentriPoint Diagnostics  (FRA:5V7) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


VentriPoint Diagnostics Market Cap Related Terms

Thank you for viewing the detailed overview of VentriPoint Diagnostics's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


VentriPoint Diagnostics Business Description

Traded in Other Exchanges
Address
18 Hook Avenue, Unit 101, Toronto, ON, CAN, M6P 1T4
VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It develops applications for heart diseases and imaging modalities which includes congenital heart disease, left or right heart failure, and normal hearts. It sells its products in Canada and internationally.

VentriPoint Diagnostics Headlines

No Headlines